Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease.

MLA

Reynolds, Samuel B., et al. “Investigating the Correlation between Small Molecular Inhibitor Utilization, Peripheral Blood Monocytes, and Treatment Outcomes in Rosai Dorfman Disease.” Annals of Hematology, vol. 103, no. 1, Jan. 2024, pp. 37–59. EBSCOhost, https://doi.org/10.1007/s00277-023-05494-x.

APA

Reynolds, S. B., Wilcox, S., Li, Q., & Ahmed, A. Z. (2024). Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease. Annals of Hematology, 103(1), 37–59. https://doi.org/10.1007/s00277-023-05494-x

Chicago

Reynolds, Samuel B, Sabrina Wilcox, Qing Li, and Asra Z Ahmed. 2024. “Investigating the Correlation between Small Molecular Inhibitor Utilization, Peripheral Blood Monocytes, and Treatment Outcomes in Rosai Dorfman Disease.” Annals of Hematology 103 (1): 37–59. doi:10.1007/s00277-023-05494-x.